Article
Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes.
Experimental hematology - 1 Dec 2012
Novak Rachel L, Harper David P, Caudell David, Slape Christopher, Beachy Sarah H, Aplan Peter D
Abstract excerpt
NUP98-HOXD13 (NHD13) and CALM-AF10 (CA10) are oncogenic fusion proteins produced by recurrent chromosomal translocations in patients with acute myeloid leukemia (AML). Transgenic mice that express these fusions develop AML with a long latency and incomplete penetrance, suggesting that collaborating genetic events are required for leukemic transformation. We employed genetic techniques to identify both preleukemic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
